Login / Signup

Using machine learning for mortality prediction and risk stratification in atezolizumab-treated cancer patients: Integrative analysis of eight clinical trials.

Yougen WuWenyu ZhuJing WangLvwen LiuWei ZhangYang WangJindong ShiJu XiaYuting GuQingqing QianYang Hong
Published in: Cancer medicine (2022)
RF model has good performance in mortality prediction and risk stratification for cancer patients receiving atezolizumab monotherapy.
Keyphrases
  • clinical trial
  • cardiovascular events
  • papillary thyroid
  • open label
  • cardiovascular disease
  • coronary artery disease
  • squamous cell carcinoma
  • lymph node metastasis
  • placebo controlled